IBO
AMEX · Pharmaceuticals
Impact Biomedical Inc
$4.10
-0.30 (-6.82%)
Open$4.39
Previous Close$4.40
Day High$4.39
Day Low$4.05
52W High$10.47
52W Low$2.43
Volume—
Avg Volume19.1K
Market Cap38.02M
P/E Ratio48.18
EPS$-0.09
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.3K | 2.01M | 2.09M |
| Net Income | -3,478,927 | 252.5K | 255.6K |
| Profit Margin | -36,993.8% | 12.5% | 12.2% |
| EBITDA | -921,656 | 413.4K | 402.4K |
| Free Cash Flow | — | 302.8K | 206.2K |
| Rev Growth | — | +12.9% | +6.5% |
| Debt/Equity | 0.05 | 0.52 | 0.58 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |